Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

354 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of immunotherapy according to the age threshold of 80 years.
Mebarki S, Pamoukdjian F, Pierro M, Poisson J, Baldini C, Widad Lahlou, Taieb J, Fabre E, Canoui-Poitrine F, Oudard S, Paillaud E. Mebarki S, et al. Among authors: baldini c. Bull Cancer. 2023 May;110(5):570-580. doi: 10.1016/j.bulcan.2023.02.010. Epub 2023 Mar 7. Bull Cancer. 2023. PMID: 36894391 Review.
Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study.
Charton E, Baldini C, Fayet Y, Schultz E, Auroy L, Vallier E, Italiano A, Robert M, Coquan E, Isambert N, Moreau P, Touzeau C, Le Tourneau C, Ghrieb Z, Kiladjian JJ, Delord JP, Gomez Roca C, Vey N, Barlesi F, Lesimple T, Penel N, Soria JC, Massard C, Besle S. Charton E, et al. Among authors: baldini c. ESMO Open. 2023 Aug;8(4):101610. doi: 10.1016/j.esmoop.2023.101610. Epub 2023 Aug 1. ESMO Open. 2023. PMID: 37536254 Free PMC article.
Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncology.
Alouani E, Laparra A, Perret A, Sakkal M, Messayke S, Danlos FX, Ouali K, Hollebecque A, Even C, Ammari S, Baldini C, Champiat S, Besse B, Robert C, Guettier C, Samuel D, Lambotte O, De Martin E, Michot JM. Alouani E, et al. Among authors: baldini c. Eur J Cancer. 2023 Nov;193:113313. doi: 10.1016/j.ejca.2023.113313. Epub 2023 Aug 26. Eur J Cancer. 2023. PMID: 37748398
Profile and outcome of cancer patients enrolled in contemporary phase I trials.
Alouani E, Gazzah A, Mercier S, Bahleda R, Hollebecque A, Michot JM, Baldini C, Ammari S, Champiat S, Marabelle A, Postel-Vinay S, Ribrag V, Loriot Y, Aix SP, Mahjoubi L. Alouani E, et al. Among authors: baldini c. Eur J Cancer. 2023 Jul;188:1-7. doi: 10.1016/j.ejca.2023.04.006. Epub 2023 Apr 20. Eur J Cancer. 2023. PMID: 37178645 Clinical Trial.
Infections occurring following IL6 blockade for the management of cytokine release syndrome in onco-hematology patients.
Valery M, Saleh K, Ecea R, Michot JM, Ribrag V, Fizazi K, Hollebecque A, Lecesne A, Ponce S, Loriot Y, Champiat S, Baldini C, Sarkozy C, Castilla-Llorente C. Valery M, et al. Among authors: baldini c. Cancer Chemother Pharmacol. 2023 Sep;92(3):229-233. doi: 10.1007/s00280-023-04551-6. Epub 2023 Jun 24. Cancer Chemother Pharmacol. 2023. PMID: 37354233
Rethinking care management for older adults with cancer: Proposals from the "PRIORITES AGE CANCER" French group.
Galvin A, Bertrand N, Boulahssass R, De Decker L, Dorval E, Clairaz B, Castaignède M, Mourey L, Baldini C, Bauvin E, Jacques B, Mallon I, Durand-Zaleski I, Guérin O, Krouri S, Soubeyran P. Galvin A, et al. Among authors: baldini c. J Geriatr Oncol. 2024 Jan;15(1):101608. doi: 10.1016/j.jgo.2023.101608. Epub 2023 Sep 6. J Geriatr Oncol. 2024. PMID: 37684193 No abstract available.
354 results